Dr. Anna Melissa Murillo, MD

Dr. Murillo practices at Roger Williams Medical Center in Providence, Rhode Island, part of CharterCARE Health Partners.

Dr. Murillo's NPI, 1316139090, was assigned on August 15, 2007. Dr. Murillo graduated from University of Santo Tomas in 2003. Dr. Murillo's Kentucky license number on file is 45080.

Dr. Murillo's primary practice is Roger Williams Medical Center, at 825 Chalkstone Avenue, Providence, RI 02908 in Providence County. The practice phone is (401) 456-2025.

Dr. Murillo's primary practice is Roger Williams Medical Center in Providence, Rhode Island, part of CharterCARE Health Partners. Dr. Murillo is also affiliated with Trinity Hospital. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Murillo to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murillo practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Murillo's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Murillo is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Murillo's licenses on file in 7 states: Kentucky, Maryland, North Dakota, Ohio, Florida, New Mexico and West Virginia.

Dmand AI lists chronic leukemia, colorectal cancer, lung cancer, lymphoma and prostate cancer among the conditions Dr. Murillo treats.

CMS data shows 95 Medicare services from Dr. Murillo across 2 procedure codes in 2024, all of them office visits, for 90 Medicare patients. Medicare paid $7,897 for them. Every service was in an office.

CMS counts 90 Medicare patients who saw Dr. Murillo in 2024. The largest group is 65 to 74, with 44 patients. 72% of them have high cholesterol, and 71% have high blood pressure. 18% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Murillo's median patient age at 73, with 59% women.

In 2024, Dr. Murillo wrote 79 Medicare Part D claims for 21 patients. 67% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $23,033 in total drug cost. In 2023, CMS named 39 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Murillo for performance year 2024, reported as part of a group. Dr. Murillo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 142 general payments to Dr. Murillo from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 65% of the total. AstraZeneca Pharmaceuticals LP paid the most, $679.

Dr. Murillo graduated from University of Santo Tomas in 2003.

Dr. Murillo is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.